Betadine Effect on Nasal Mucosa Cilia

首次发布于 2020 年 7 月 7 日

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

计划入组 295 人 · 首次发布于 2022 年 1 月 21 日

A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

计划入组 11 人 · 首次发布于 2024 年 8 月 13 日

SA ClfA inhibitors(Sichuan University)

Argentina Repeals Restrictive Pharmaceutical Patent Guidelines, Sparking Industry Debate Over Generic Drug Access

CARVYKTI® Demonstrates Significant Benefit in High-Risk Multiple Myeloma After One Line of Therapy

Cilta-cel Demonstrates Sustained Survival Benefit in Pretreated Multiple Myeloma